Phathom Pharmaceuticals, Inc. PHAT Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s operating income?
- Phathom Pharmaceuticals, Inc. (PHAT) reported operating income of -$15.48M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s operating income changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s operating income increased by 80.4% year-over-year, from -$78.86M to -$15.48M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s operating income?
- Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s operating income has grown at a 4.3% compound annual growth rate (CAGR), from -$135.08M to -$159.99M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.